ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

INAB IN8bio Inc

0,9821
-0,0179 (-1,79%)
10 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
IN8bio Inc INAB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0179 -1,79% 0,9821 01:50:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,01 0,98 1,03 1,01 1,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.5.202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202422:04EDGAR2Form 8-K - Current report
09.5.202422:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
07.5.202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30.4.202412:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
24.4.202414:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
16.4.202422:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
09.4.202422:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
14.3.202421:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
05.3.202422:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
26.2.202414:00BWIN8bio to Present at Upcoming Investor Conferences
14.2.202414:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
08.2.202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
19.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
18.1.202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12.1.202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
04.1.202414:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
15.12.202322:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15.12.202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202314:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202312:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.12.202312:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.12.202323:15EDGAR2Form 8-K - Current report
11.12.202322:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
11.12.202315:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
11.12.202314:56EDGAR2Form 8-K - Current report
08.12.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202322:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
07.12.202322:15EDGAR2Form 8-K - Current report
07.12.202314:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
05.12.202314:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
20.11.202315:04EDGAR2Form 8-K - Current report
20.11.202313:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10.11.202313:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
09.11.202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:03EDGAR2Form 8-K - Current report
09.11.202322:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..
06.11.202314:00GLOBEIN8bio Presents Biologic Correlative Data from the INB-200..
03.11.202317:00GLOBEIN8bio Presents Positive Data Update from Induced..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock